| [1] |
SELUK L, TALIANSKY A, YONATH H, et al. A large screen for paraneoplastic neurological autoantibodies;diagnosis and predictive values[J]. Clin Immunol, 2019, 199:29-36.
DOI
URL
|
| [2] |
PETERSON K, ROSENBLUM M K, KOTANIDES H, et al. Paraneoplastic cerebellar degeneration. Ⅰ. A clinical analysis of 55 anti-Yo antibody-positive patients[J]. Neurology, 1992, 42(10):1931-1937.
DOI
URL
|
| [3] |
MCKEON A, TRACY J A, PITTOCK S J, et al. Purkinje cell cytoplasmic autoantibody type 1 accompaniments:the cerebellum and beyond[J]. Arch Neurol, 2011, 68(10):1282-1289.
DOI
URL
|
| [4] |
DARNELL R B, POSNER J B. Paraneoplastic syndromes involving the nervous system[J]. N Engl J Med, 2003, 349(16):1543-1554.
DOI
URL
|
| [5] |
GIOMETTO B, GRISOLD W, VITALIANI R, et al. Paraneoplastic neurologic syndrome in the PNS Euronetwork database:a European study from 20 centers[J]. Arch Neurol, 2010, 67(3):330-335.
DOI
URL
|
| [6] |
GRAUS F, DELATTRE J Y, ANTOINE J C, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes[J]. J Neurol Neurosurg Psychiatry, 2004, 75(8):1135-1140.
DOI
URL
|
| [7] |
VENKATRAMAN A, OPAL P. Paraneoplastic cerebellar degeneration with anti-Yo antibodies-a review[J]. Ann Clin Transl Neurol, 2016, 3(8):655-663.
DOI
URL
|
| [8] |
VEDELER C A, ANTOINE J C, GIOMETTO B, et al. Management of paraneoplastic neurological syndromes:report of an EFNS Task Force[J]. Eur J Neurol, 2006, 13(7):682-690.
DOI
URL
|
| [9] |
SADEGHIAN H, VERNINO S. Progress in the management of paraneoplastic neurological disorders[J]. Ther Adv Neurol Disord, 2010, 3(1):43-52.
DOI
URL
|
| [10] |
SUTTON I J, FURSDON DAVIS C, ESIRI M M, et al. Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus[J]. Ann Neurol, 2001, 49(2):253-257.
DOI
URL
|
| [11] |
HASADSRI L, LEE J, WANG B H, et al. Anti-yo associated paraneoplastic cerebellar degeneration in a man with large cell cancer of the lung[J]. Case Rep Neurol Med, 2013, 2013:725936.
|
| [12] |
AMYES E, CURNOW J, STARK Z, et al. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration[J]. J Neuroimmunol, 2001, 114(1-2):259-264.
DOI
URL
|
| [13] |
HIDA C, TSUKAMOTO T, AWANO H, et al. Ultrastructural localization of anti-Purkinje cell antibody-binding sites in paraneoplastic cerebellar degeneration[J]. Arch Neurol, 1994, 51(6):555-558.
DOI
URL
|
| [14] |
JARIUS S, WILDEMANN B. 'Medusa head ataxia':the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3:anti-Yo/CDR2,anti-Nb/AP3B2,PCA-2,anti-Tr/DNER,other antibodies,diagnostic pitfalls,summary and outlook[J]. J Neuroinflammation, 2015, 12:168.
DOI
URL
|
| [15] |
ABOUL-ENEIN F, HÖFTBERGER R, BUXHOFER-AUSCH V, et al. Neocortical neurones may be targeted by immune attack in anti-Yo paraneoplastic syndrome[J]. Neuropathol Appl Neurobiol, 2008, 34(2):248-252.
DOI
URL
|
| [16] |
LITVAN I, BHATIA K P, BURN D J, et al. Movement Disorders Society Scientific Issues Committee report:SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders[J]. Mov Disord, 2003, 18(5):467-486.
DOI
URL
|
| [17] |
JANKOVIC J. Progressive supranuclear palsy:paraneoplastic effect of bronchial carcinoma[J]. Neurology, 1985, 35(3):446-447.
|
| [18] |
GOLBE L I, MILLER D C, DUVOISIN R C. Paraneoplastic degeneration of the substantia nigra with dystonia and parkinsonism[J]. Mov Disord, 1989, 4(2):147-152.
DOI
URL
|
| [19] |
TAN J H, GOH B C, TAMBYAH P A, et al. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma[J]. Parkinsonism Relat Disord, 2005, 11(3):187-191.
DOI
URL
|
| [20] |
MATSUMOTO L, YAMAMOTO T, HIGASHIHARA M, et al. Severe hypokinesis caused by paraneoplastic anti-Ma2 encephalitis associated with bilateral intratubular germ-cell neoplasm of the testes[J]. Mov Disord, 2007, 22(5):728-731.
DOI
URL
|
